A Study of Danazol's Safety

Susan S. Jick, Marian Wald Myers
In: Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · 1995 · vol. 15(6) , pp. 740–741 · doi:10.1002/j.1875-9114.1995.tb02890.x · W4388195074
article OA: closed CC0
View on OpenAlex View at publisher

Abstract

In a review of medical records of 530 recipients of danazol at Group Health Cooperative of Puget Sound, we identified 154 (29%) people who reported at least one adverse event that occurred within 45 days after receiving the drug. In no patient did the event require hospitalization, and there were no known long‐term sequelae.

My notes (saved in your browser only)

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

References (2)

Source provenance

openalex
last seen: 2026-05-11T06:58:05.965230+00:00
License: CC0 · commercial use OK